Amnis, a Washington-based developer of instrumentation for high speed cell imaging for research and diagnostic markets, has launched new FlowSight imaging flow cytometer.
Amnis said the modular compact 12-channel FlowSight can be upgraded in the factory or the field with up to four lasers.
It can also be upgraded with a 96-well AutoSampler and a Quantitative Imaging package to meet the needs of a broad range of users.
Amnis CEO David Basiji said with 12 detection channels, visual verification of every cell, and affordable pricing, the FlowSight is designed to serve the needs of beginners and expert flow cytometrists, alike.
"The FlowSight complements Amnis’ flagship ImageStreamX imaging flow cytometer, a high resolution microscope for cells in fluid suspension that enables numerous image-based assays in rare sub-populations," Basiji said.
Amnis president and COO William Ortyn said the FlowSight is based on the proven ImageStreamX architecture and shares its remarkable fluorescence sensitivity, exceeding that of high-end conventional flow cytometers by five-fold or more.